Skip to main content
Log in

Allogeneic bone marrow transplantation (BMT) for refractory Behçet's disease with severe CNS involvement

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

References

  1. Siva A, Altintas A, Saip S . Behçet's syndrome and the nervous system. Curr Opin Neurol 2004; 17: 347–357.

    Article  Google Scholar 

  2. Yurdakul S, Hamuryndan V, Yazici H . Behçet's syndrome. Curr Opin Rheumatol 2004; 18: 38–42.

    Article  Google Scholar 

  3. Marmont AM, Gualandi F, Van Lint MT, Bacigalupo A . Autologous hematopoietic stem cell transplant for refractory Behçet's disease. Bone Marrow Transplant 2003; 31 (Suppl 1): 15 (Abstract).

    Google Scholar 

  4. Rossi G, Moretta A, Locatelli F . Autologous hematopoietic stem cell transplantation for severe/refractory intestinal Behçet's disease. Blood 2004; 103: 748–750.

    Article  CAS  Google Scholar 

  5. Maurer B, Hensel M, Max R, Fiehn C, Ho AD, Lorenz HM . Autologous hematopoietic stem-cell transplantation for Behçet's disease with pulmonary involvement: analysis after 5 years of follow up. Ann Rheum Dis 2006; 65: 127–129.

    Article  CAS  Google Scholar 

  6. Yamato K . Successful cord blood stem cell transplantation for myelodysplastic syndrome with Behçet's disease. Int J Hematol 2003; 77: 82–85.

    Article  Google Scholar 

  7. International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078–1080.

  8. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI et al. Rapid hematopoietic recovery after coinfusion of autologous blood stem cells and culture-expanded marrow Mesenchymal Stem Cells in advanced breast cancer patients receiving high dose chemotherapy. J Clin Oncol 2000; 18: 307–316.

    Article  CAS  Google Scholar 

  9. Saruhan-Direskenely G, Yentur SP, Akman-Demir G, Isik N, Serdaroglu P . Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol 2003; 145: 127–134.

    Article  Google Scholar 

  10. Sun W, Popat U, Hutton G, Zang YCQ, Krance R, Carrum G et al. Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis. Brain 2004; 127: 996–1008.

    Article  Google Scholar 

  11. Muraro PA, Douek DC, Packer A, Chung K, Guenaga FA, Cassiani-Ingoni R et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005; 201: 805–816.

    Article  CAS  Google Scholar 

  12. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439–1441.

    Article  Google Scholar 

  13. Bacigalupo A . Mesenchymal stem cells and haematopoietic stem cell transplantation. Best Practice Res Clin Haematol 2004; 17: 387–399.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The mesenchymal stem cells cultures were supported by a grant of the Cassa di Risparmio di Genova e Imperia (CARIGE).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A M Marmont.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marmont, A., Gualandi, F., Piaggio, G. et al. Allogeneic bone marrow transplantation (BMT) for refractory Behçet's disease with severe CNS involvement. Bone Marrow Transplant 37, 1061–1063 (2006). https://doi.org/10.1038/sj.bmt.1705372

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705372

  • Springer Nature Limited

This article is cited by

Navigation